Poseida Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Poseida Therapeutics

11/03/2022 07:04

* Poseida Therapeutics Inc  PSTX.OQ  reported quarterly
adjusted
earnings of 2 cents​​ per share for the quarter ended in
December. The mean expectation of four analysts for the quarter
was for a loss of 35 cents per share.
    * Revenue was $31.24 million​;  analysts expected $15.83
million. 
    * Poseida Therapeutics Inc's reported EPS for the quarter
was 2
cents​.
    * The mean earnings estimate of analysts had fallen by
about 51.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Poseida Therapeutics Inc shares had fallen by 48.6% this
quarter.
    * The company reported quarterly net income of $1.47
million.
    * Wall Street's median 12-month price target for Poseida
Therapeutics Inc is $21.50 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated March 11 at 07:04 a.m.  ​All
figures in US dollars unless otherwise stated